Company Legal Name
Latest Valuation
Founded Year
Headquarter
Doctolib operates a comprehensive software suite that enables European healthcare providers to manage patient appointments, deliver telehealth services, and maintain medical records through a unified digital platform. Founded in 2013 and headquartered in Paris, the company has established itself as a leading healthcare technology provider across Europe, serving thousands of medical practitioners and healthcare facilities. Doctolib's platform streamlines administrative workflows while improving patient access to care through online booking and virtual consultation capabilities. The company continues to expand its market presence across European markets while enhancing its technology offerings to support the ongoing digitalization of healthcare services.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





